CanPath promo fr
New CCRA Advisory Board Chair and Elected Representative
Effective January 1, 2026, CCRA welcomes new CCRA Advisory Board chair, Dr. James (Jim) Woodgett. Jim is the President and Scientific Director of the Terry Fox Research Institute (TFRI), a Senior Scientist at the Lunenfeld-Tanenbaum Research Institute at Sinai... Read More »
Effective January 1, 2026, CCRA welcomes new CCRA Advisory Board chair, Dr. James (Jim) Woodgett. Jim is the President and Scientific Director of the Terry Fox Research Institute (TFRI), a Senior Scientist at the Lunenfeld-Tanenbaum Research Institute at Sinai... Read More »
The 3CTN EDI Framework and Toolkit is Launched
The Canadian Cancer Clinical Trials Network (3CTN) and its collaborative partners are thrilled to announce the launch of an Equity, Diversity, and Inclusion (EDI) Framework and companion Toolkit designed to support the Canadian research community in embedding EDI best practices within clinical tri... Read More »
The Canadian Cancer Clinical Trials Network (3CTN) and its collaborative partners are thrilled to announce the launch of an Equity, Diversity, and Inclusion (EDI) Framework and companion Toolkit designed to support the Canadian research community in embedding EDI best practices within clinical tri... Read More »